Blood transfusions and the subsequent risk of hematologic malignancies
Authors:
- 24 May 2010
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 50 (10) , 2249-2257
Abstract
BACKGROUND: Blood transfusions are associated with viral transmission and immunomodulation, perhaps increasing subsequent risk of hematologic malignancies (HMs). Prior studies of transfusion recipients have lacked details on specific HM subtypes.STUDY DESIGN AND METHODS: Risk of HM after blood transfusion was evaluated in a US population‐based case‐control study (77,488 elderly HM cases identified through cancer registries, 154,509 controls). Transfusions were identified using linked Medicare hospitalization claims. Polytomous logistic regression was used to calculate odds ratios (ORs) associating transfusion and HM subtypes by features suggestive of a causal relationship.RESULTS: A history of transfusion was present in 7.9% of HM cases versus 5.9% of controls. Associations for most HM subtypes suggested reverse causality: ORs were elevated only during the shortest latency periods; ORs for unspecified anemia and gastrointestinal bleeding, which may be related to undiagnosed HM, were stronger than for surgeries, which are unlikely to be related to HM; and/or there was no dose response. In contrast, risk for lymphoplasmacytic lymphoma (1397 cases) was elevated at long latency (OR, 1.56 at 10+ years after transfusion), after transfusions related to surgeries (OR, 1.22‐1.47), and in a dose‐response relationship with number of transfusion‐related hospitalizations (OR, 1.53 with one hospitalization; OR, 1.80 with two or more hospitalizations, p trend < 0.0001). Risk for marginal zone lymphoma (1915 cases) was also elevated at 10+ years after transfusion (OR, 1.80).CONCLUSION: Consistent with prior studies, blood transfusions did not increase risk of most HM subtypes. Patterns of elevated risk for lymphoplasmacytic and marginal zone lymphomas suggest an etiologic role for transfusion.Keywords
This publication has 36 references indexed in Scilit:
- Increased Risk for Lymphoid and Myeloid Neoplasms in Elderly Solid-Organ Transplant RecipientsCancer Epidemiology, Biomarkers & Prevention, 2010
- Common immune‐related risk factors and incident non‐Hodgkin lymphoma: The multiethnic cohortInternational Journal of Cancer, 2009
- Genetics- and Immune-Related Factors in the Pathogenesis of Lymphoplasmacytic Lymphoma/Waldenström's MacroglobulinemiaClinical Lymphoma Myeloma and Leukemia, 2009
- Infectious aetiology of Hodgkin and non‐Hodgkin lymphomas: a review of the epidemiological evidenceJournal of Internal Medicine, 2008
- Hematopoietic Malignancies Associated with Viral and Alcoholic HepatitisCancer Epidemiology, Biomarkers & Prevention, 2008
- Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph)Blood, 2007
- Patterns of age‐ and sex‐specific prevalence of major blood‐borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor studyTransfusion, 2004
- Allogeneic blood transfusion as a risk factor for the subsequent development of non-Hodgkin's lymphomaTransfusion Medicine Reviews, 2000
- Cancer morbidity in blood recipients—Results of a cohort studyEuropean Journal of Cancer, 1993
- AN INCREASE OF DONOR-SPECIFIC T HELPER PRECURSORS RESULTING FROM BLOOD TRANSFUSIONSTransplantation, 1990